Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies
International Journal of Molecular Sciences · 04.01.2023 · 24 (2) · 923
DOI: 10.3390/ijms24020923 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.01.2023. Verfasst von Farzaneh Darbeheshti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, institutional funds.
Abstract (Originalsprache)
Low-level tumor somatic DNA mutations in tissue and liquid biopsies obtained from cancer patients can have profound implications for development of metastasis, prognosis, choice of treatment, follow-up, or early cancer detection. Unless detected, such low-frequency DNA alterations can misinform patient management decisions or become missed opportunities for personalized medicine. Next-generation sequencing technologies and digital-PCR can resolve low-level mutations but require access to specialized instrumentation, time, and resources. Enzymatic-based approaches to detection of low-level mutations provide a simple, straightforward, and affordable alternative to enrich and detect such alterations and is broadly available to low-resource laboratory settings. This review summarizes the traditional uses of enzymatic mutation detection and describes the latest exciting developments, potential, and applications with specific reference to the field of liquid biopsy in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.
ORCID-Profile: Farzaneh Darbeheshti, G Mike Makrigiorgos
Förderung
- NCI NIH HHS
- institutional funds
Zitieren
APA
Darbeheshti, F., & Makrigiorgos, G. M. (2023). Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies. International Journal of Molecular Sciences, 24(2), 923. https://doi.org/10.3390/ijms24020923
Vancouver
Darbeheshti F, Makrigiorgos GM. Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies. International Journal of Molecular Sciences. 2023;24(2):923. doi:10.3390/ijms24020923
BibTeX
@article{Darbeheshti2023,
author = {Darbeheshti, Farzaneh and Makrigiorgos, G Mike},
title = {Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {923},
doi = {10.3390/ijms24020923}
}
EUVIMED